vtgn: the cashflow

MyFinsight

For the quarter ending 2025-09-30.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Net cash provided by financing activities	29,142	1,488
Net change in cash and cash equivalents	-4,345	-18,146
Cash and cash equivalents at beginning of period	67,131	-
Cash and cash equivalents at end of period	62,786	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

For the quarter ending 2025-09-30.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Net cash provided by financing activities	29,142	1,488
Net change in cash and cash equivalents	-4,345	-18,146
Cash and cash equivalents at beginning of period	67,131	-
Cash and cash equivalents at end of period	62,786	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Vistagen Therapeutics, Inc. (VTGN)